Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 2512:30 AM EDT
-01:30 AM EDT
At one point, she believed GMAT wasn’t for her. After scoring 595, self-doubt crept in and she questioned her potential. But instead of quitting, she made the right strategic changes. The result? A remarkable comeback to 695. Check out how Saakshi did it.
Apr 2601:30 AM EDT
-02:30 AM EDT
Learn how Keshav, a Chartered Accountant, scored an impressive 705 on GMAT in just 30 days with GMATWhiz's expert guidance. In this video, he shares preparation tips and strategies that worked for him, including the mock, time management, and more.
Apr 2610:00 AM EDT
-11:00 AM EDT
The Target Test Prep course represents a quantum leap forward in GMAT preparation, a radical reinterpretation of the way that students should study. Try before you buy with a 5-day, full-access trial of the course for FREE!
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
May 0111:00 AM PDT
-12:00 PM PDT
Free- full-length test + 15 concept videos + 150+ short videos + study plan!
Abhi077
SC Moderator
Joined: 25 Sep 2018
Last visit: 18 Apr 2025
Posts: 1,084
Given Kudos: 1,665
Location: United States (CA)
Concentration: Finance, Strategy
Schools: Rotman '21 Jindal '21 Stern '21
GPA: 3.97
WE:Investment Banking (Finance: Investment Banking)
Products:
16 May 2020, 22:55
Kudos
Bookmarks
C
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
85%
(hard)
Question Stats:
49% (02:08) correct
51%
(02:21)
wrong
based on 419
sessions
History
Date
Time
Result
Not Attempted Yet
Wipla Pharmas has come up with a new vaccine for Valian Flu, a very common ailment in the city of Croone. The vaccine has 80% fewer side effects than the currently widely used vaccine marketed by Wipla’s chief competitor, Hoopla Pharmas but Wipla’s vaccine is costlier. The medical fraternity is all set to bring about a discontinuation in the use of vaccines that have more than five cited side effects in the next year or so. Hoopla’s current vaccine has at least 15 cited side effects and Hoopla is unlikely to come up with a new vaccine with less than 5 side effects in the next year or so. Therefore, once the discontinuation in the use of vaccines with more than 5 side effects becomes effective, Wipla’s vaccine should register good sales after that.
Which of the following is an assumption on which the argument depends?
A. The Valian Flu afflicts a significant proportion of the population every year.
B. Wipla R & D department is working on identifying a cheaper method of producing the vaccines on a large scale.
C. The other vaccine producing pharmaceutical companies in Croone have not been able to come up with a vaccine that is comparable to Wipla’s.
D. People will be as willing to try out Wipla’s vaccine as they have been to try out Hoopla’s vaccine.
E. Most people will not find the price of Wipla’s vaccine a big deterrent in the way of using it.
Which of the following is an assumption on which the argument depends?
A. The Valian Flu afflicts a significant proportion of the population every year.
B. Wipla R & D department is working on identifying a cheaper method of producing the vaccines on a large scale.
C. The other vaccine producing pharmaceutical companies in Croone have not been able to come up with a vaccine that is comparable to Wipla’s.
D. People will be as willing to try out Wipla’s vaccine as they have been to try out Hoopla’s vaccine.
E. Most people will not find the price of Wipla’s vaccine a big deterrent in the way of using it.
Source- GMATWhiz
NiftyNiffler
McCombs School Moderator
Joined: 26 May 2019
Last visit: 15 Aug 2021
Posts: 324
Given Kudos: 151
Location: India
Schools: INSEAD Jan '20 LSE MFin "21 McCombs '23 Tepper '23
GMAT 1: 690 Q50 V33
Products:
19 May 2020, 06:58
Kudos
Bookmarks
Wipla Pharmas has come up with a new vaccine for Valian Flu, a very common ailment in the city of Croone. The vaccine has 80% fewer side effects than the currently widely used vaccine marketed by Wipla’s chief competitor, Hoopla Pharmas but Wipla’s vaccine is costlier. The medical fraternity is all set to bring about a discontinuation in the use of vaccines that have more than five cited side effects in the next year or so. Hoopla’s current vaccine has at least 15 cited side effects and Hoopla is unlikely to come up with a new vaccine with less than 5 side effects in the next year or so. Therefore, once the discontinuation in the use of vaccines with more than 5 side effects becomes effective, Wipla’s vaccine should register good sales after that.
Which of the following is an assumption on which the argument depends?
A. The Valian Flu afflicts a significant proportion of the population every year. -- The proportion of population doesn't matter as the plan is that the sales of Wipla pharma will replace those of Hoopla Pharma
B. Wipla R & D department is working on identifying a cheaper method of producing the vaccines on a large scale. -- Even if Wipla doesn't come up with a cheaper option, with the removal of its chief competitor, it could still win the market with higher-priced vaccines
C. The other vaccine producing pharmaceutical companies in Croone have not been able to come up with a vaccine that is comparable to Wipla’s. -- CORRECT, this assumption says that in absence of Wipla's chief competition, new breed of competitors won't crop up which provide vaccines which are cheap and have less-than-5-side-effects.
D. People will be as willing to try out Wipla’s vaccine as they have been to try out Hoopla’s vaccine. -- In absence of other better alternatives, people might have no choice. This also doesn't connect to the underlying assumption for the conclusion to stand on.
E. Most people will not find the price of Wipla’s vaccine a big deterrent in the way of using it. -- This might weaken the sale but won't obliterate Woopla's chances.
So, the answer is C
Which of the following is an assumption on which the argument depends?
A. The Valian Flu afflicts a significant proportion of the population every year. -- The proportion of population doesn't matter as the plan is that the sales of Wipla pharma will replace those of Hoopla Pharma
B. Wipla R & D department is working on identifying a cheaper method of producing the vaccines on a large scale. -- Even if Wipla doesn't come up with a cheaper option, with the removal of its chief competitor, it could still win the market with higher-priced vaccines
C. The other vaccine producing pharmaceutical companies in Croone have not been able to come up with a vaccine that is comparable to Wipla’s. -- CORRECT, this assumption says that in absence of Wipla's chief competition, new breed of competitors won't crop up which provide vaccines which are cheap and have less-than-5-side-effects.
D. People will be as willing to try out Wipla’s vaccine as they have been to try out Hoopla’s vaccine. -- In absence of other better alternatives, people might have no choice. This also doesn't connect to the underlying assumption for the conclusion to stand on.
E. Most people will not find the price of Wipla’s vaccine a big deterrent in the way of using it. -- This might weaken the sale but won't obliterate Woopla's chances.
So, the answer is C
19 May 2020, 07:40
Kudos
Bookmarks
Wipla Pharmas has come up with a new vaccine for Valian Flu, a very common ailment in the city of Croone. The vaccine has 80% fewer side effects than the currently widely used vaccine marketed by Wipla’s chief competitor, Hoopla Pharmas but Wipla’s vaccine is costlier. The medical fraternity is all set to bring about a discontinuation in the use of vaccines that have more than five cited side effects in the next year or so. Hoopla’s current vaccine has at least 15 cited side effects and Hoopla is unlikely to come up with a new vaccine with less than 5 side effects in the next year or so. Therefore, once the discontinuation in the use of vaccines with more than 5 side effects becomes effective, Wipla’s vaccine should register good sales after that.
Which of the following is an assumption on which the argument depends?
A. The Valian Flu afflicts a significant proportion of the population every year.
(This is not relevant.This means that there will be more demand but does not address why Wipla will benefit in particular.)
B. Wipla R & D department is working on identifying a cheaper method of producing the vaccines on a large scale.
(This does not talk about the benefit after discontinuation in the use of vaccines with more than 5 side effects becomes effective )
C. The other vaccine producing pharmaceutical companies in Croone have not been able to come up with a vaccine that is comparable to Wipla’s.
(This is correct option.Since the only competitor Hoopla will not be able produce vaccine as it has more side effects than allowed and also if no other pharma companies will be able to come up with a vaccine comparable to Wipla,then obviously sales of vaccine produced by Wipla will increase. )
D. People will be as willing to try out Wipla’s vaccine as they have been to try out Hoopla’s vaccine.
(This is not relevant to the context.This nowhere leads to reason why Wipla's sales will increase in current scenario.)
E. Most people will not find the price of Wipla’s vaccine a big deterrent in the way of using it.
(This will not lead to more sales in given scenario )
Which of the following is an assumption on which the argument depends?
A. The Valian Flu afflicts a significant proportion of the population every year.
(This is not relevant.This means that there will be more demand but does not address why Wipla will benefit in particular.)
B. Wipla R & D department is working on identifying a cheaper method of producing the vaccines on a large scale.
(This does not talk about the benefit after discontinuation in the use of vaccines with more than 5 side effects becomes effective )
C. The other vaccine producing pharmaceutical companies in Croone have not been able to come up with a vaccine that is comparable to Wipla’s.
(This is correct option.Since the only competitor Hoopla will not be able produce vaccine as it has more side effects than allowed and also if no other pharma companies will be able to come up with a vaccine comparable to Wipla,then obviously sales of vaccine produced by Wipla will increase. )
D. People will be as willing to try out Wipla’s vaccine as they have been to try out Hoopla’s vaccine.
(This is not relevant to the context.This nowhere leads to reason why Wipla's sales will increase in current scenario.)
E. Most people will not find the price of Wipla’s vaccine a big deterrent in the way of using it.
(This will not lead to more sales in given scenario )
